Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marcy K. Vallone"'
Autor:
Mark K. Bennett, Christopher J. Molineaux, Tina M. Woo, Marcy K. Vallone, Congcong M. Sun, Mark S. Smyth, Kevin D. Shenk, Francesco Parlati, Evan R. Lewis, Guy J. Laidig, Jing Jiang, Mark N. Ho, Maya Dajee, Tonia J. Buchholz, Monette A. Aujay, Christopher J. Kirk, Susan D. Demo
Supplementary Figure 1 from Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a101c8883eaf41acd7d210a2605a14a
https://doi.org/10.1158/0008-5472.22367433.v1
https://doi.org/10.1158/0008-5472.22367433.v1
Autor:
Mark K. Bennett, Christopher J. Molineaux, Tina M. Woo, Marcy K. Vallone, Congcong M. Sun, Mark S. Smyth, Kevin D. Shenk, Francesco Parlati, Evan R. Lewis, Guy J. Laidig, Jing Jiang, Mark N. Ho, Maya Dajee, Tonia J. Buchholz, Monette A. Aujay, Christopher J. Kirk, Susan D. Demo
Supplementary Figure 2 from Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6bf03b50a24a2f24a2702fa914794b3
https://doi.org/10.1158/0008-5472.22367430.v1
https://doi.org/10.1158/0008-5472.22367430.v1
Autor:
Mark K. Bennett, Christopher J. Molineaux, Tina M. Woo, Marcy K. Vallone, Congcong M. Sun, Mark S. Smyth, Kevin D. Shenk, Francesco Parlati, Evan R. Lewis, Guy J. Laidig, Jing Jiang, Mark N. Ho, Maya Dajee, Tonia J. Buchholz, Monette A. Aujay, Christopher J. Kirk, Susan D. Demo
Clinical studies with bortezomib have validated the proteasome as a therapeutic target for the treatment of multiple myeloma and non-Hodgkin's lymphoma. However, significant toxicities have restricted the intensity of bortezomib dosing. Here we descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47fe217774fa4900e95086b10a5be1f2
https://doi.org/10.1158/0008-5472.c.6495546.v1
https://doi.org/10.1158/0008-5472.c.6495546.v1